Mobile phlebotomists conducted at-home blood draws for patients enrolled in Freenome’s trial. [Photo courtesy of Phleb-Finders]
This colorectal cancer screening study enrolled 35,000 patients across the continental U.S.Chuanbo Xu, Freenome
Cancer doesn’t discriminate.
It’s the second-leading cause of death in the U.S. Early detection is key in treating — and even preventing — cancers like colorectal cancer (CRC).
Despite recommendations that everyone over the age of 45 be screened for CRC, nearly a third of people don’t get screened. This lack of screening helps make CRC the second-deadliest cancer in the U.S.
For some, taking a few days off work for a colonoscopy is inconvenient. For others, the bowel preparation or stool experience can be uncomfortable or unnerving.
To improve adherence and reduce these kinds of barriers, Freenome is developing a test that’s convenient, …